GNMX
Aevi Genomic Medicine Inc
GNMX
GNMX
Delisted
GNMX was delisted on the 3rd of February, 2020.
69 hedge funds and large institutions have $94.1M invested in Aevi Genomic Medicine Inc in 2016 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 26 increasing their positions, 15 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
69
Holding in Top 10
1
Calls
$99K
Puts
–
Top Buyers
| 1 | +$4.72M | |
| 2 | +$2.5M | |
| 3 | +$2.18M | |
| 4 |
BC
Broadfin Capital
New York
|
+$1.8M |
| 5 |
PA
Perceptive Advisors
New York
|
+$1.67M |
Top Sellers
| 1 | -$260K | |
| 2 | -$203K | |
| 3 | -$163K | |
| 4 |
Citigroup
New York
|
-$107K |
| 5 |
QF
QVT Financial
New York
|
-$101K |